FindTrial
Sign In

Pharmacogenomic Testing

OTHER11 trials

Sponsors

Wake Forest University Health Sciences, University of Rochester, J.J.Swen, Columbia University, John Papastergiou Pharmacy Ltd

Conditions

Adverse Drug EventAdverse Drug ReactionAnxietyDepressionDepressive DisorderDrug Drug InteractionElderlyGeneralized Anxiety Disorder

Phase 2

LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients
TerminatedNCT02542397
Wake Forest University Health SciencesMalignant Tumor of Ill-defined Site
Start: 2015-09-30End: 2019-06-30Updated: 2022-11-03

Phase 4

Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes
TerminatedNCT02932579
University of RochesterPain
Start: 2017-07-01End: 2021-01-13Updated: 2022-03-16

Unknown Phase

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions
CompletedNCT03093818
J.J.SwenAdverse Drug Reaction
Start: 2017-03-20End: 2021-05-01Updated: 2024-04-19
Pharmacogenomic Testing in Major Depressive Disorder
TerminatedNCT03228953
Columbia UniversityMajor Depressive Disorder
Start: 2017-08-01End: 2019-07-17Updated: 2022-10-12
Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy
CompletedNCT03591224
John Papastergiou Pharmacy LtdAnxiety, Depression, Generalized Anxiety Disorder +2
Start: 2018-04-17End: 2019-12-31Updated: 2020-07-07
Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment
CompletedNCT03803293
Mayo ClinicHealthy Subjects
Start: 2012-07-13End: 2019-12-31Updated: 2021-10-07
Implementation of a Pharmacist-led Pharmacogenomic Clinical Service
WithdrawnNCT04984538
Tabula Rasa HealthCareAdverse Drug Event, Drug Drug Interaction, Elderly +1
Start: 2021-07-01End: 2023-01-30Updated: 2023-02-01
Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting
NCT05053815
Tabula Rasa HealthCarePharmacogenomics, Polypharmacy
Start: 2021-11-02End: 2024-03-01Target: 1500Updated: 2022-09-02
A Single-center Randomized Controlled Study on the Effect of Pharmacogenomics Trial on Clinical Efficacy in Patients With Depression
CompletedNCT05959187
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityDepressive Disorder, Pharmacogenomic Drug Interaction
Start: 2020-07-15End: 2023-03-30Updated: 2023-07-25
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
Not yet recruitingNCT06744712
Wake Forest University Health SciencesPediatric Cancer
Start: 2026-06-01End: 2028-07-01Target: 130Updated: 2026-03-25
PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)
RecruitingNCT06907784
NHS Greater Glasgow and ClydePharmacogenomic Drug Interaction
Start: 2025-04-09End: 2026-09-30Target: 2000Updated: 2025-09-19

Related Papers

Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity - A secondary analysis of the PREPARE trial.
2025-09-25
Reporting Adverse Drug Events: A Comparison of an Online Patient Tool Versus Telephone-Based Monitoring in Community Pharmacy Patients in the Netherlands
Drug Safety2025-06-14
Clinical Benefits and Utility of Pretherapeutic <i>DPYD</i> and <i>UGT1A1</i> Testing in Gastrointestinal Cancer
JAMA Network Open2024-12-0614 citations
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
2023-02-01336 citations
Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial
Clinical and Translational Science2021-02-2845 citations
Development of Rapid Pharmacogenomic Testing Assay in a Mobile Molecular Biology Laboratory (2MoBiL)
OMICS A Journal of Integrative Biology2020-10-167 citations
Pharmacogenetic (PGx) guided cancer pain management in an oncology palliative medicine (PM) clinic.
Journal of Clinical Oncology2019-11-011 citations